Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01718 is a long non-coding RNA gene that is differentially expressed in certain cancers, notably lung cancer, and is a candidate diagnostic biomarker. It is not an enzyme, receptor, transporter, or transcription factor, but rather is classified as a long intergenic non-coding RNA (lincRNA). LINC01718 encodes a long intergenic non-coding RNA molecule, meaning it does not code for a protein and is located between protein-coding genes in the genome. LINC01718 has been proposed as a diagnostic biomarker for lung cancer based on comparative expression analyses in lung cancer tissues versus healthy controls; specifically, it is one of several lncRNAs that show altered expression and strong discriminative power for classifying cancerous samples. While many lincRNAs are implicated in the epigenetic regulation and post-transcriptional modulation of gene expression, the detailed molecular function of LINC01718 remains to be characterized and is the subject of ongoing research. Its utility is primarily in the context of disease biomarker studies rather than as a direct drug target or receptor. In summary, LINC01718 is a biomarker lincRNA, not a protein-coding therapeutic target, and its main significance lies in cancer diagnosis—especially for lung cancer—rather than in direct molecular targeting by drugs.
Not applicable. No mechanism of action for drugs targeting this molecule is described in the literature
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1718 (LINC01718).